Reduction in Neutrophil-Lymphocyte Ratio During Initial Concurrent Chemoradiotherapy Is Prognostic for Survival of Glioblastoma Patients

Mason, M. T., McNamara, M. G., Tieu, M. T., Lwin, Z., Millar, B. A., Menard, C., Laperriere, N., Milosevic, M., Mason, W. P. and Chung, C. (2014). Reduction in Neutrophil-Lymphocyte Ratio During Initial Concurrent Chemoradiotherapy Is Prognostic for Survival of Glioblastoma Patients. In: Neuro-Oncology. 11th Congress of the European-Association-of-Neuro-Oncology, Turin Italy, (). Oct 09-12, 2014.

Author Mason, M. T.
McNamara, M. G.
Tieu, M. T.
Lwin, Z.
Millar, B. A.
Menard, C.
Laperriere, N.
Milosevic, M.
Mason, W. P.
Chung, C.
Title of paper Reduction in Neutrophil-Lymphocyte Ratio During Initial Concurrent Chemoradiotherapy Is Prognostic for Survival of Glioblastoma Patients
Conference name 11th Congress of the European-Association-of-Neuro-Oncology
Conference location Turin Italy
Conference dates Oct 09-12, 2014
Proceedings title Neuro-Oncology   Check publisher's open access policy
Journal name Neuro-Oncology   Check publisher's open access policy
Publisher OXFORD UNIV PRESS INC
Publication Year 2014
Sub-type Published abstract
ISSN 1522-8517
Volume 16
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Sub-type: Published abstract
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Sat, 24 Mar 2018, 01:00:25 EST by Web Cron on behalf of Learning and Research Services (UQ Library)